3 Best Gene Therapy Stocks of 2018 (So Far)

In less than four months in the second half of 2017, the FDA approved the first gene therapy for fighting cancer and the first gene therapy targeting an inherited disease. As you might expect, gene therapy -- which involves the insertion of a healthy gene into cells to modify DNA -- has begun to really take off in 2018.